related documents
- 249 Targeting recurrent glioblastoma with ROBO1 CAR T cells Conferences
- 323 Development of nuclear envelope protein-targeting CAR T cells for treatment of hyperproliferative MYC -driven group 3 medulloblastoma Conferences
- 716 A randomized phase II window of opportunity clinical trial of PD-1 +/- IL-4 inhibition in early-stage ER+ HER2- breast cancer Conferences